Clearance Reports · 2025 · November

FDA 510(k) Clearances - November 2025

204 medical devices cleared by the FDA. Data sourced from the FDA 510(k) public files.

204
Cleared
16
Specialties
151d
Avg review

November 2025 overview

The FDA cleared 204 medical devices in November 2025 through the 510(k) premarket notification pathway. This compares to 304 clearances in October 2025 - a decrease of 100 (-32.9%).

Radiology led all specialties with 34 cleared devices. The fastest average review was Pathology at 88 days. The slowest was Microbiology at 195 days.

Overall average review time: 151 days, ranging from 1 to 459 days. The FDA's standard 510(k) review target is 90 days.

Clearances by specialty - November 2025

Detailed data

Review time in calendar days from FDA receipt to decision. Source: FDA 510(k) downloadable files.

Specialty Cleared Avg days Min Max vs October
Radiology 34 149 23 282 -2
General & Plastic Surgery 32 129 44 447 -27
Orthopedic 29 140 54 446 -20
Neurology 20 188 61 403 +3
Dental 18 131 1 256 -8
Cardiovascular 16 170 55 459 -17
General Hospital 12 151 48 259 -3
Microbiology 10 195 57 426 -
Physical Medicine 9 141 23 268 +3
Gastroenterology & Urology 7 149 49 269 -20
Anesthesiology 6 187 168 260 +2
Chemistry 4 134 44 236 -1
Obstetrics & Gynecology 3 127 99 154 -5
Ophthalmic 2 157 46 267 -1
Toxicology 1 97 97 97 -
Pathology 1 88 88 88 +1
Total 204 151 1 459 -100

Key observations

Fastest reviews

The fastest individual clearance took 1 day. Reviews under 5 days typically reflect Special 510(k) submissions for minor modifications to already-cleared devices.

Longest review

The longest individual review reached 459 days. Extended reviews typically indicate additional information requests or complex predicate device questions. The FDA's standard target is 90 days from receipt.

Leading specialty: Radiology

Radiology led November 2025 with 34 clearances - 17% of all monthly clearances.

Review time spread

Microbiology posted the highest average at 195 days. Pathology was fastest at 88 days. The gap of 107 days between fastest and slowest specialties reflects differences in device complexity and regulatory pathway.

Most active manufacturers

The most active manufacturers in November 2025 were Siemens Medical Solutions USA, Inc. (3) , Guangzhou Potent Medical Equipment Joint-Stock Co., Ltd. (3) , Roche Molecular Systems, Inc. (3) , Karl Storz SE & CO. KG (2) and Fresenius Medical Care Renal Therapies Group, LLC (2) . Together, these five manufacturers accounted for 13 of the 204 total clearances - 6% of all November activity.

About this data

This report covers FDA 510(k) submissions with a decision date in November 2025 and a valid days-to-decision value. Data is sourced from the FDA 510(k) public files, published on the 5th of each month and in the public domain (17 U.S.C. § 105). Only cleared decisions are counted (SESE, SESK, SESU, SEKD, SESP, SESD, ST, SN).

Maintained by Space Bits, S.L. Not affiliated with or endorsed by the FDA. Verify at accessdata.fda.gov.